Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
Group 1 (newly diagnosed patients):
- People newly diagnosed with advanced-stage (stage IIIC or IV) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer between December 2013 and December 2024.
- Complete records of their initial cancer treatment and any maintenance therapy must be available.
- Follow-up health information after treatment must be available.
Group 2 (patients whose cancer has returned):
- People diagnosed between December 2013 and December 2024 with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has come back for the first time and is responding to platinum-based chemotherapy (a common type of cancer drug).
- The cancer must have come back at least 6 months after finishing the last course of platinum-based chemotherapy.
- Complete records of their second round of treatment and any maintenance therapy must be available.
- Follow-up health information after treatment must be available.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
Group 1:
- People whose cancer is a non-epithelial type, a borderline tumour, a clear cell carcinoma, or a mucinous carcinoma.
- People whose records of initial treatment or follow-up information are incomplete or missing.
Group 2:
- People whose cancer is a non-epithelial type, a borderline tumour, a clear cell carcinoma, or a mucinous carcinoma.
- People whose cancer has come back a second time.
- People whose cancer did not respond well to platinum-based chemotherapy — for example, if the cancer progressed during treatment or within 6 months of finishing it.
- People whose records of their second-line treatment or follow-up information are incomplete or missing.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Overall Mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.